These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14114008)

  • 1. POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS.
    FOX SL
    JAMA; 1964 Apr; 188():320-1. PubMed ID: 14114008
    [No Abstract]   [Full Text] [Related]  

  • 2. COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.
    EISEN MJ
    JAMA; 1964 Jul; 189():64-5. PubMed ID: 14149032
    [No Abstract]   [Full Text] [Related]  

  • 3. TREATMENT OF THE PATIENT WITH GOUT.
    DENKO CW
    Ohio State Med J; 1963 Nov; 59():1098-101. PubMed ID: 14083462
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF PRETREATMENT WITH COLCHICINE ON THE INFLAMMATORY RESPONSE TO MICROCRYSTALLINE URATE: A MODEL FOR GOUTY INFLAMMATION.
    MALAWISTA SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():648-57. PubMed ID: 14274829
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF SULFINPYRAZONE ON SERUM URIC ACID IN GOUT. A LONG-TERM STUDY.
    KUZELL WC; GLOVER RP; GIBBS JO; BLAU RA
    Geriatrics; 1964 Dec; 19():894-909. PubMed ID: 14226251
    [No Abstract]   [Full Text] [Related]  

  • 6. [CORTICOSTEROID THERAPY OF GOUT].
    ROBECCHI A
    Minerva Med; 1964 Oct; 55():3269-76. PubMed ID: 14225464
    [No Abstract]   [Full Text] [Related]  

  • 7. GOUT IN THE ELDERLY. MODERN MANAGEMENT IN HISTORICAL PERSPECTIVE.
    MCCORMICK EW
    Geriatrics; 1965 Sep; 20():756-8. PubMed ID: 14333673
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACUTE RECURRENT OLIGOARTICULAR GOUT. (STIMULATION OF RHEUMATOID ARTHRITIS)].
    GRAVANO L
    Dia Med; 1964 Apr; 36():325-32. PubMed ID: 14152386
    [No Abstract]   [Full Text] [Related]  

  • 10. A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES.
    PEREL JM; SNELL MM; CHEN W; DAYTON PG
    Biochem Pharmacol; 1964 Sep; 13():1305-17. PubMed ID: 14221728
    [No Abstract]   [Full Text] [Related]  

  • 11. THE TREATMENT OF GOUT.
    TREADWELL B
    N Z Med J; 1964 Sep; 63():567-74. PubMed ID: 14210072
    [No Abstract]   [Full Text] [Related]  

  • 12. OXYPHENBUTAZONE IN TREATMENT OF DYSMENORRHEA.
    MENDEL EB
    Tex State J Med; 1965 Jan; 61():44-7. PubMed ID: 14226985
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLINICAL EXPERIMENTS WITH METABOLITE I OF PHENYLBUTAZONE (G 27-202) IN THE TREATMENT OF VARIOUS INFECTIOUS DISEASES AND RHEUMATIC DISEASES].
    FERREIRA EB
    Hospital (Rio J); 1963 Dec; 64():1431-43. PubMed ID: 14122572
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.
    YU TF; PATON BC; CHENKIN T; BURNS JJ; BRODIE BB; GUTMAN AB
    J Clin Invest; 1956 Apr; 35(4):374-85. PubMed ID: 13306779
    [No Abstract]   [Full Text] [Related]  

  • 15. The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone.
    Rosen A
    Biochem Pharmacol; 1970 Jun; 19(6):2075-81. PubMed ID: 5513975
    [No Abstract]   [Full Text] [Related]  

  • 16. HAEMATURIA AND ANTICOAGULANTS.
    REILLY EB; PERRY A; FUJITA K; NAKAMURA RM
    Lancet; 1964 Mar; 1(7332):554. PubMed ID: 14100201
    [No Abstract]   [Full Text] [Related]  

  • 17. [How to treat gout].
    Sans Solá L
    Rev Esp Reum Enferm Osteoartic; 1966 Jul; 11(7):497-523. PubMed ID: 4297957
    [No Abstract]   [Full Text] [Related]  

  • 18. DRUGS FOR GOUT.
    OGRYZLO MA
    Can Med Assoc J; 1964 Feb; 90(9):589-90. PubMed ID: 14118703
    [No Abstract]   [Full Text] [Related]  

  • 19. [OBSERVATIONS OF COMPLICATIONS OCCURRING IN GOUT PATIENTS DURING TREATMENT].
    SERANE J; PEAN C
    Rein Foie; 1965; 7():259-65. PubMed ID: 14337645
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interactions. II. Binding of some pyrazolone and pyrazolidine derivatives to bovine serum albumin.
    Ozeki S; Tejima K
    Chem Pharm Bull (Tokyo); 1974 Jun; 22(6):1297-301. PubMed ID: 4472458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.